| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |